Evidence map›Paper›PMID 25714926›Full record

ArticleeLife2015

Angiopoietin-like proteins stimulate HSPC development through interaction with notch receptor signaling.

Michelle I Lin, Emily N Price, Sonja Boatman, Elliott J Hagedorn, Eirini Trompouki, Sruthi Satishchandran, Charles W Carspecken, Audrey Uong, Anthony DiBiase, Song Yang and 9 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Inflammation in Development and Aging: Insights from the Zebrafish Model.International journal of molecular sciences · 2024
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. The zebrafish: A fintastic model for hematopoietic development and disease.Wiley interdisciplinary reviews. Developmental biology · 2018
    Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 1 country.

Michelle I LinStem Cell Program and Division of Hematology/Oncology, Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, United States.
Emily N PriceStem Cell Program and Division of Hematology/Oncology, Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, United States.
Sonja BoatmanStem Cell Program and Division of Hematology/Oncology, Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, United States.
Elliott J HagedornStem Cell Program and Division of Hematology/Oncology, Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, United States.
Eirini TrompoukiStem Cell Program and Division of Hematology/Oncology, Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, United States.
Sruthi SatishchandranStem Cell Program and Division of Hematology/Oncology, Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, United States.
Charles W CarspeckenStem Cell Program and Division of Hematology/Oncology, Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, United States.
Audrey UongStem Cell Program and Division of Hematology/Oncology, Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, United States.
Anthony DiBiaseStem Cell Program and Division of Hematology/Oncology, Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, United States.
Song YangStem Cell Program and Division of Hematology/Oncology, Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, United States.
Matthew C CanverStem Cell Program and Division of Hematology/Oncology, Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, United States.
Ann DahlbergPediatric Oncology, Clinical Division, Fred Hutchinson Cancer Research Center, Seattle, United States.
Zhigang LuDepartment of Physiology, University of Texas Southwestern Medical Center, Dallas, United States.
Cheng Cheng ZhangDepartment of Developmental Biology, University of Texas Southwestern Medical Center, Dallas, United States.
Stuart H OrkinStem Cell Program and Division of Hematology/Oncology, Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, United States.
Irwin D BernsteinPediatric Oncology, Clinical Division, Fred Hutchinson Cancer Research Center, Seattle, United States.
Jon C AsterDepartment of Pathology, Brigham and Women's Hospital, Boston, United States.
Richard M WhiteDepartment of Cancer Biology, Memorial Sloan Kettering Cancer Center, New York, United States.
Leonard I ZonStem Cell Program and Division of Hematology/Oncology, Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, United States.
Howard Hughes Medical Institute · USHarvard University · USDana-Farber Cancer Institute · USFred Hutch Cancer Center · USThe University of Texas Southwestern Medical Center · USHarvard University Press · USMemorial Sloan Kettering Cancer Center · US

Funding

TRANSCRIPTION FACTOR GATA-1 IN TERMINAL ERYTHROID DEVELOPMENTP01HL032262 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI ORKIN, STUART H · 1985 to 2021
$38.9M
SYNAPTIC MECHANISMS IN HIPPOCAMPAL EPILEPTOGENESISP30HD018655 · NICHD · CHILDREN'S HOSPITAL BOSTON · PI POMEROY, SCOTT LOREN · 1985 to 2015
$26.2M
CORE--ZEBRAFISHP30DK049216 · NIDDK · CHILDREN'S HOSPITAL BOSTON · PI ZHOU, YI · 1999 to 2015
$14.3M
Customized stem cells for clinical application in blood disordersR24DK092760 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI COLLINS, JAMES J, DALEY, GEORGE Q · 2011 to 2018
$10.7M
Expansion of Cardiac and Hematopoietic Pregenitors by Wnt and NotchU01HL100395 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BERNSTEIN, IRWIN D, MOON, RANDALL TODD · 2009 to 2015
$8.4M
Progenitor Cells inHuman Skeletal MuscleP50NS040828 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI KUNKEL, LOUIS M · 2008 to 2011
$5.9M
EMBRYONIC HEMATOPOIESISR01HL048801 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI ZON, LEONARD IRA · 1992 to 2016
$5.7M
COMPARATIVE APPROACH TO GLOBIN REGULATION/THALASSEMIAR01DK053298 · NIDDK · CHILDREN'S HOSPITAL BOSTON · PI ZON, LEONARD IRA · 1998 to 2012
$3.9M
The role of inhibitory receptors in leukemia developmentR01CA172268 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI ZHANG, CHENGCHENG · 2013 to 2017
$1.6M
The role of melanocyte precursors in zebrafish pigmentation disordersK08AR055368 · NIAMS · SLOAN-KETTERING INST CAN RESEARCH · PI WHITE, RICHARD MARK · 2009 to 2013
$635k
Canadian Institutes of Health ResearchHoward Hughes Medical InstituteNCI NIH HHS 1R01CA172268NCI NIH HHS R01 CA172268NHLBI NIH HHS 5P01HL32262-32NHLBI NIH HHS 5R01HL048801-21NHLBI NIH HHS 5U01HL10001-05NHLBI NIH HHS P01 HL032262NHLBI NIH HHS R01 HL048801NHLBI NIH HHS U01 HL100395NIAMS NIH HHS K08 AR055368NIAMS NIH HHS K08AR055368NICHD NIH HHS P30 HD018655NICHD NIH HHS P30-HD18655NIDDK NIH HHS 5P30DK49216-19NIDDK NIH HHS 5R01DK53298NIDDK NIH HHS P30 DK049216NIDDK NIH HHS R01 DK053298NIDDK NIH HHS R24 DK092760NIDDK NIH HHS R24DK092760-02NINDS NIH HHS P50 NS040828NINDS NIH HHS P50-NS40828
6 · The paper itself

Abstract

Angiopoietin-like proteins (angptls) are capable of ex vivo expansion of mouse and human hematopoietic stem and progenitor cells (HSPCs). Despite this intriguing ability, their mechanism is unknown. In this study, we show that angptl2 overexpression is sufficient to expand definitive HSPCs in zebrafish embryos. Angptl1/2 are required for definitive hematopoiesis and vascular specification of the hemogenic endothelium. The loss-of-function phenotype is reminiscent of the notch mutant mindbomb (mib), and a strong genetic interaction occurs between angptls and notch. Overexpressing angptl2 rescues mib while overexpressing notch rescues angptl1/2 morphants. Gene expression studies in ANGPTL2-stimulated CD34(+) cells showed a strong MYC activation signature and myc overexpression in angptl1/2 morphants or mib restored HSPCs formation. ANGPTL2 can increase NOTCH activation in cultured cells and ANGPTL receptor interacted with NOTCH to regulate NOTCH cleavage. Together our data provide insight to the angptl-mediated notch activation through receptor interaction and subsequent activation of myc targets.

Indexed as

Angiopoietin-Like Protein 1Angiopoietin-Like Protein 2Angiopoietin-like ProteinsAngiopoietinsAnimalsAnimals, Genetically ModifiedBlotting, WesternCells, CulturedGene Expression ProfilingGene Expression Regulation, DevelopmentalGene Knockdown TechniquesHEK293 CellsHematopoiesisHematopoietic Stem CellsHumansK562 CellsAngiopoietin-Like Protein 1Angiopoietin-Like Protein 2Angiopoietin-like ProteinsAngiopoietinsAngptl1 protein, zebrafishangptl2b protein, zebrafishANGPTL2 protein, humanLILRB2 protein, humanMembrane GlycoproteinsReceptors, ImmunologicReceptors, NotchZebrafish Proteinsangiopoietin-like proteinsdevelopmental biologyhematopoietic stem and progenitor cellsLILRB2mycnotchstem cellszebrafish

Identifiers

PMID25714926
PMCPMC4371382
OpenAlexW1977743262

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.